SOCS3 has been reported involving in the progress of various diseases such as autoimmune diseases [31], cardiovascular diseases [32], metabolic diseases [33] and tumours [34], which is responsive to an increase in IL-6 and plays a negative regulatory role in cytokine signalling [12]. Here, IL6 is linked to metabolic disease.